WuXi AppTec partnered with Fudan University to provide its NextCODE population human genomics database system and integrated research and clinical solutions to the Fudan-led Collaborative Innovation Center of Genetics and Development (CICGD), allowing CICGD scientists to perform gene sequencing and bioinformatics analysis with greater speed. 
 
WuXi NextCODE offers solutions for genomic medicine, from CLIA sequencing to bioinformatics, clinical interpretation, and diagnostic test development and delivery. Its technology is being used to analyze and manage whole-genome data on 350,000 people. 
 
“We are delighted to partner with Fudan University, a top university and a pillar of genetic research in China, to promote genomics research and its applications,” said Dr. Ge Li, chairman and chief executive officer of WuXi AppTec. “The partnership integrates WuXi’s world-leading genomics platform with China’s leading research and innovation capabilities to bring the latest technological and medical advances closer to patients in China and around the world.”
 
“WuXi NextCODE’s genome analysis technology is the best in the world, and it underpins the most advanced and largest-scale genomics research currently being conducted,” said Dr. Li Jin, director of CICGD and vice president of Fudan University. “Fudan’s partnership with WuXi will turn Shanghai into a premier global innovation center for human genomics. We are thrilled at the opportunity to work with WuXi’s unrivalled genomic data management and clinical data analysis system, which will undoubtedly enhance CICGD’s research and application capabilities in genetics and genomics.”